A distinct expression profile separates Turkish and Australian melanocytic naevi

logical, pathological, and cytogenetic analysis of three cases. Skeletal Radiol. 2012; 41; 237–244. 13. Aouad R, Matar N, Sader-Ghorra C, Haddad A. Pathology quiz case 1. Oncocytic lipoadenoma of the parotid gland. Arch. Otolaryngol. Head Neck Surg. 2008; 134; 446–448. 14. Chahwala Q, Siddaraju N, Singh N, Goneppanavar M, Basu D. Fine needle aspiration cytology of oncocytic lipoadenoma of the parotid gland: report of a rare case. Acta Cytol. 2009; 53; 437–439. 15. Ilie M, Hofman V, Pedeutour F, Attias R, Santini J, Hofman P. Oncocytic lipoadenoma of the parotid gland: immunohistochemical and cytogenetic analysis. Pathol. Res. Pract. 2010; 206; 66–72. 16. Klieb HB, Perez-Ordonez B. Oncocytic lipoadenoma of the parotid gland with sebaceous differentiation. Study of its keratin profile. Virchows Arch. 2006; 449; 722–725. 17. McNeil ML, Bullock MJ, Trites JR, Hart RD, Taylor SM. Oncocytic lipoadenoma of the parotid gland with sebaceous differentiation in a 73-year-old male. J. Otolaryngol. Head Neck Surg. 2010; 39; E48–E50. 18. Mitsimponas KT, Agaimy A, Schlittenbauer T, Nkenke E, Neukam FW. Oncocytic lipoadenoma of the parotid gland: a report of a new case and review of the literature. Int. J. Clin. Exp. Pathol. 2012; 5; 1000–1006. 19. Pusiol T, Franceschetti I, Scialpi M, Piscioli I. Oncocytic sialolipoma of the submandibular gland with sebaceous differentiation: a new pathological entity. Indian J. Pathol. Microbiol. 2009; 52; 379–382. 20. Tokyol C, Dilek FH, Aktepe F, Aycicek A, Altuntas A. Oncocytic lipoadenoma of the parotid gland: a case report with fine needle aspiration cytology findings. Kulak Burun Bogaz Ihtis. Derg. 2010; 20; 146–149. 21. Chi CL, Kuo TT, Lee LY. Oncocytic lipoadenoma: a rare case of parotid gland tumor and review of the literature. J. Pathol. Transl. Med. 2015; 49; 144–147. 22. Lau SK, Thompson LD. Oncocytic lipoadenoma of the salivary gland: a clinicopathologic analysis of 7 cases and review of the literature. Head Neck Pathol. 2015; 9; 39–46. 23. Parmar HV. Oncocytic lipoadenoma of submandibular gland: a case report. J. Clin. Diagn. Res. 2015; 9; ED05–ED06. 24. Fletcher C, Bridge J, Hogendoorn P, Mertens F eds World Health Organization Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC Press, 2013.

[1]  P. Fox,et al.  Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations , 2014, Clinical Cancer Research.

[2]  Y. Choi,et al.  Signaling through cyclin D-dependent kinases , 2014, Oncogene.

[3]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[4]  S. Chanock,et al.  Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families , 2013, The Journal of investigative dermatology.

[5]  Jan V Hirschmann,et al.  Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. , 2012, Journal of the American Academy of Dermatology.

[6]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. , 2012, Journal of the American Academy of Dermatology.

[7]  K. Duffy,et al.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. , 2012, Journal of the American Academy of Dermatology.

[8]  A. Fernandez-Flores.  Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community. , 2010, The American Journal of dermatopathology.

[9]  Sheng Chen.  The dysplastic nevus controversy: It is not about the nevus per se but one's belief in the multistep tumorigenesis theory. , 2010, The American Journal of dermatopathology.

[10]  K. Katsuoka,et al.  Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma. , 2010, European journal of dermatology : EJD.

[11]  D. Bishop,et al.  Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival , 2009, Clinical Cancer Research.

[12]  C. Bertolotto,et al.  SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation , 2007, Proceedings of the National Academy of Sciences.

[13]  A. Hlobilková,et al.  Nestin expression in cutaneous melanomas and melanocytic nevi , 2007, Journal of cutaneous pathology.

[14]  L. Chin,et al.  Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. O. Thomas,et al.  HMG1 and 2: architectural DNA-binding proteins. , 2001, Biochemical Society transactions.

[16]  R. Vollmer,et al.  Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. , 1999, Human pathology.

[17]  M Greenacre,et al.  Correspondence analysis in medical research , 1992, Statistical methods in medical research.